Publication Information

{'id': 'https://openalex.org/W1926172964', 'doi': 'https://doi.org/10.1016/s0022-3565(24)36655-8', 'title': 'Vasodilator Action of Calcium Antagonists in Coronary Arteries In Vitro', 'display_name': 'Vasodilator Action of Calcium Antagonists in Coronary Arteries In Vitro', 'publication_year': 1997, 'publication_date': '1997-05-01', 'ids': {'openalex': 'https://openalex.org/W1926172964', 'doi': 'https://doi.org/10.1016/s0022-3565(24)36655-8', 'mag': '1926172964', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/9152367'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0022-3565(24)36655-8', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S102125482', 'display_name': 'Journal of Pharmacology and Experimental Therapeutics', 'issn_l': '0022-3565', 'issn': ['0022-3565', '1521-0103'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5082899793', 'display_name': 'Stanley Kalsner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I174216632', 'display_name': 'City University of New York', 'ror': 'https://ror.org/00453a208', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I174216632']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Stanley Kalsner', 'raw_affiliation_strings': ['Department of Physiology and Pharmacology, City University of New York Medical School, Sophie Davis School of Biomedical Education, New York, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Physiology and Pharmacology, City University of New York Medical School, Sophie Davis School of Biomedical Education, New York, USA.', 'institution_ids': ['https://openalex.org/I174216632']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5082899793'], 'corresponding_institution_ids': ['https://openalex.org/I174216632'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.519, 'has_fulltext': False, 'cited_by_count': 12, 'citation_normalized_percentile': {'value': 0.577383, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 79, 'max': 80}, 'biblio': {'volume': '281', 'issue': '2', 'first_page': '634', 'last_page': '642'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10155', 'display_name': 'Nitric Oxide and Endothelin Effects', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10155', 'display_name': 'Nitric Oxide and Endothelin Effects', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11001', 'display_name': 'Renin-Angiotensin System Studies', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10169', 'display_name': 'Protein Kinase Regulation and GTPase Signaling', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tetraethylammonium', 'display_name': 'Tetraethylammonium', 'score': 0.45213714}], 'concepts': [{'id': 'https://openalex.org/C2779066535', 'wikidata': 'https://www.wikidata.org/wiki/Q39111', 'display_name': 'Nifedipine', 'level': 3, 'score': 0.85661185}, {'id': 'https://openalex.org/C2776741139', 'wikidata': 'https://www.wikidata.org/wiki/Q422229', 'display_name': 'Diltiazem', 'level': 3, 'score': 0.8133776}, {'id': 'https://openalex.org/C519063684', 'wikidata': 'https://www.wikidata.org/wiki/Q706', 'display_name': 'Calcium', 'level': 2, 'score': 0.7660681}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.6425606}, {'id': 'https://openalex.org/C2777022698', 'wikidata': 'https://www.wikidata.org/wiki/Q410291', 'display_name': 'Verapamil', 'level': 3, 'score': 0.5712813}, {'id': 'https://openalex.org/C18699975', 'wikidata': 'https://www.wikidata.org/wiki/Q14905735', 'display_name': 'Voltage-dependent calcium channel', 'level': 3, 'score': 0.50646126}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4859151}, {'id': 'https://openalex.org/C2779395532', 'wikidata': 'https://www.wikidata.org/wiki/Q7916469', 'display_name': 'Vascular smooth muscle', 'level': 3, 'score': 0.48087385}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.46127605}, {'id': 'https://openalex.org/C85520022', 'wikidata': 'https://www.wikidata.org/wiki/Q15322916', 'display_name': 'Calcium channel', 'level': 3, 'score': 0.45578757}, {'id': 'https://openalex.org/C2776050358', 'wikidata': 'https://www.wikidata.org/wiki/Q127006', 'display_name': 'Muscle contraction', 'level': 2, 'score': 0.4533689}, {'id': 'https://openalex.org/C2779133857', 'wikidata': 'https://www.wikidata.org/wiki/Q285911', 'display_name': 'Ouabain', 'level': 3, 'score': 0.45282868}, {'id': 'https://openalex.org/C2781295685', 'wikidata': 'https://www.wikidata.org/wiki/Q410728', 'display_name': 'Tetraethylammonium', 'level': 3, 'score': 0.45213714}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.4478171}, {'id': 'https://openalex.org/C517785266', 'wikidata': 'https://www.wikidata.org/wiki/Q703', 'display_name': 'Potassium', 'level': 2, 'score': 0.29884714}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.24591848}, {'id': 'https://openalex.org/C537181965', 'wikidata': 'https://www.wikidata.org/wiki/Q658', 'display_name': 'Sodium', 'level': 2, 'score': 0.1614759}, {'id': 'https://openalex.org/C2992686903', 'wikidata': 'https://www.wikidata.org/wiki/Q208453', 'display_name': 'Smooth muscle', 'level': 2, 'score': 0.07578313}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001158', 'descriptor_name': 'Arteries', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D003331', 'descriptor_name': 'Coronary Vessels', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D014664', 'descriptor_name': 'Vasodilation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001158', 'descriptor_name': 'Arteries', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D001158', 'descriptor_name': 'Arteries', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002118', 'descriptor_name': 'Calcium', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D002118', 'descriptor_name': 'Calcium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002417', 'descriptor_name': 'Cattle', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003331', 'descriptor_name': 'Coronary Vessels', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D003331', 'descriptor_name': 'Coronary Vessels', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004110', 'descriptor_name': 'Diltiazem', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004110', 'descriptor_name': 'Diltiazem', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066298', 'descriptor_name': 'In Vitro Techniques', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009543', 'descriptor_name': 'Nifedipine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D009543', 'descriptor_name': 'Nifedipine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D026902', 'descriptor_name': 'Potassium Channel Blockers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012433', 'descriptor_name': 'Ryanodine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D012433', 'descriptor_name': 'Ryanodine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014664', 'descriptor_name': 'Vasodilation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0022-3565(24)36655-8', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S102125482', 'display_name': 'Journal of Pharmacology and Experimental Therapeutics', 'issn_l': '0022-3565', 'issn': ['0022-3565', '1521-0103'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316283', 'host_organization_name': 'American Society for Pharmacology and Experimental Therapeutics', 'host_organization_lineage': ['https://openalex.org/P4310316283'], 'host_organization_lineage_names': ['American Society for Pharmacology and Experimental Therapeutics'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9152367', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 32, 'referenced_works': ['https://openalex.org/W119193584', 'https://openalex.org/W1485099091', 'https://openalex.org/W1516221483', 'https://openalex.org/W1963113608', 'https://openalex.org/W1970056747', 'https://openalex.org/W1981721115', 'https://openalex.org/W1982019761', 'https://openalex.org/W1987128815', 'https://openalex.org/W1989062752', 'https://openalex.org/W1996196738', 'https://openalex.org/W2006871477', 'https://openalex.org/W2018029907', 'https://openalex.org/W2021727957', 'https://openalex.org/W2024378782', 'https://openalex.org/W2046291488', 'https://openalex.org/W2054290984', 'https://openalex.org/W2065990963', 'https://openalex.org/W2137006447', 'https://openalex.org/W2141627729', 'https://openalex.org/W2142746098', 'https://openalex.org/W2145828535', 'https://openalex.org/W2149906835', 'https://openalex.org/W2164089782', 'https://openalex.org/W2188313731', 'https://openalex.org/W2226096574', 'https://openalex.org/W2249214832', 'https://openalex.org/W2342174312', 'https://openalex.org/W2410475964', 'https://openalex.org/W2414816440', 'https://openalex.org/W2418214378', 'https://openalex.org/W2478883803', 'https://openalex.org/W2725806147'], 'related_works': ['https://openalex.org/W597691413', 'https://openalex.org/W4250893062', 'https://openalex.org/W3145524995', 'https://openalex.org/W2419478150', 'https://openalex.org/W2189220773', 'https://openalex.org/W2131572345', 'https://openalex.org/W2056647123', 'https://openalex.org/W2026745212', 'https://openalex.org/W2011996693', 'https://openalex.org/W179011299'], 'abstract_inverted_index': {'Calcium': [0], 'antagonists': [1, 220], 'have': [2], 'routinely': [3], 'been': [4], 'assumed': [5], 'to': [6, 46, 66, 74, 108, 119, 150, 153, 173, 176, 179], 'inhibit': [7], 'the': [8, 39, 61, 164, 200, 215, 226], 'contractions': [9, 26, 152, 175, 202], 'of': [10, 16, 21, 33, 38, 43, 51, 63, 84, 130, 146, 166, 188, 214, 218, 228, 245, 247], 'arterial': [11, 222], 'smooth': [12, 232], 'muscle': [13, 233], 'through': [14, 250], 'block': [15, 174, 246], 'membrane': [17, 251], 'channels.': [18, 253], 'The': [19], 'effects': [20, 217], 'nifedipine': [22, 85, 131, 147], 'and': [23, 71, 73, 92, 98], 'diltiazem': [24, 94], 'on': [25, 221], 'were': [27, 79, 112, 125, 148, 171], 'examined': [28], 'in': [29, 30, 57, 60, 105, 122, 136, 157, 160, 163, 184, 190, 204], 'vitro': [31], 'preparations': [32, 158, 189], 'cattle': [34], 'coronary': [35], 'artery,': [36], 'one': [37], 'key': [40], 'therapeutic': [41, 216], 'targets': [42], 'calcium': [44, 116, 219, 238, 248], 'antagonists,': [45], 'determine': [47], 'if': [48], 'alternate': [49], 'mechanisms': [50], 'action': [52], 'are': [53], 'involved.': [54], 'Contractions': [55, 103, 118], 'elicited': [56, 134, 183, 203], 'calcium-free': [58, 106, 123, 161, 185, 191, 205], 'Krebs,': [59], 'presence': [62, 165], 'U': [64], '46619,': [65], 'potassium': [67, 180], 'channel': [68, 181], 'inhibitors': [69, 182], '(4-aminopyridine': [70], 'tetraethylammonium)': [72], 'a': [75], 'Na(+)-K(+)-ATPase': [76], 'inhibitor': [77], '(ouabain),': [78], 'antagonized': [80, 113, 126], 'by': [81, 93, 115], 'low': [82], 'concentrations': [83, 129, 145], '(3': [86, 95], 'x': [87, 89, 96, 100], '10(-9)-3': [88], '10(-8)': [90, 97], 'M)': [91], '1': [99], '10(-7)': [101], 'M).': [102], 'produced': [104, 156], 'Krebs': [107, 124, 137, 162, 192], 'KCl': [109, 167, 177], '(50': [110, 168], 'mM)': [111], 'similarly': [114], 'antagonists.': [117], 'depolarizing': [120], 'agents': [121], 'at': [127, 211, 230, 236], 'lower': [128], 'than': [132, 170, 244], 'comparably': [133], 'responses': [135], 'containing': [138], '2.3': [139], 'mM': [140], 'calcium.': [141], 'In': [142], 'addition,': [143], 'higher': [144], 'required': [149], 'antagonize': [151], 'extracellular': [154], 'calcium,': [155], 'maintained': [159], 'mM),': [169], 'needed': [172], 'or': [178, 241], 'Krebs.': [186, 206], 'Pretreatment': [187], 'with': [193], 'ryanodine': [194], '(30': [195], 'microM)': [196], 'did': [197], 'not': [198], 'reduce': [199], 'nifedipine-sensitive': [201], 'It': [207], 'is': [208, 239], 'concluded': [209], 'that': [210], 'least': [212], 'some': [213], 'tone': [223], 'may': [224], 'be': [225], 'consequence': [227], 'antagonism': [229], 'vascular': [231], 'cell': [234], 'site(s)': [235], 'which': [237], 'released': [240], 'interacts,': [242], 'rather': [243], 'entry': [249], 'L': [252]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1926172964', 'counts_by_year': [], 'updated_date': '2025-01-06T03:51:28.102381', 'created_date': '2016-06-24'}